Driving research, providing support and improving outcomes for patients and their families affected by rare conditions

Currently Funded Research

The Myrovlytis Trust  has funded over £6 million of BHD research. See the research projects we are currently funding below. The success rate for our 2022 grant funding round was 36%.

Current BHD Research Projects Funded by the Myrovlytis Trust

Professor Stefan Marciniak, University of Cambridge, UK
Determining the Prevalence of Pathogenic FLCN Variants from Large Genomic Registries

Learn more about Stefan’s research project here.

Dr Neil Rajan, Newcastle University, UK
Delineating the Cutaneous Tumour Microenvironment in Birt-Hogg-Dubé Syndrome

Learn more about Neil’s research project here.

Dr Arjan Houweling, Amsterdam UMC, The Netherlands
Improving Care for Birt-Hogg-Dubé Syndrome Patients: Clinical and Genetic Analysis of a Unique Cohort

Learn more about Arjan’s research project here.

Current Osteosarcoma Research Projects Funded by the Myrovlytis Trust

Professor Nancy DeMore, Medical University of South Carolina, USA
Combination Therapy with a Humanized Monoclonal Antibody to Secreted Frizzled Related Protein 2 for Metastatic Osteosarcoma

Learn more about Nancy’s research project here.

Professor Graham Cook and Dr Fiona Errington-Mais, University of Leeds, UK
Oncolytic Virus-based Activation of Natural Killer Cells for the Immunotherapy of Osteosarcoma

Learn more about Graham and Fiona’s research project here.



Osteosarcoma Institute
Bardo Foundation
Rare Revolution Magazine
Gene People logo
Gene People logo
Sarcoma Patient advocacy Global Network
Connect with us…
Back to top